ArticleNagoya journal of medical science2019

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study.

Nao Takano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.